Autor: |
Guida, JP, Costa, ML, Parpinelli, MA, Pacagnella, RC, Ferreira, EC, Mayrink, J, Silveira, C, Souza, RT, Sousa, MH, Say, L, Chou, D, Filippi, V, Barreix, M, Barbour, K, McCaw-Binns, A, von Dadelszen, P, Cecatti, JG, Andreucci, CB, Angelini, CR, Ferraz, JP, Zanardi, DM, Camargo, RS, Cottler, S, Fawole, O, Firoz, T, Gadama, L, Ghérissi, A, Gyte, G, Hindin, M, Jayathilaka, A, Kalamar, A, Kone, Y, Kostanjsek, N, Lange, I, Magee, LA, Mathur, A, Morgan, M, Munjanja, S, Gichuhi, GN, Petzold, M, Sullivan, E, Taulo, F, Tunçalp, Ö, Vanderkruik, R |
Rok vydání: |
2018 |
Předmět: |
|
Popis: |
© 2018 World Health Organization; licensed by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics. Objective: To assess the scores of postpartum women using the WHO Disability Assessment Schedule 2.0 36-item tool (WHODAS-36), considering different morbidities. Methods: Secondary analysis of a retrospective cohort of women who delivered at a referral maternity in Brazil and were classified with and without severe maternal morbidity (SMM). WHODAS-36 was used to assess functioning in postpartum women. Percentile distribution of total WHODAS score was compared across three groups: Percentile (P)90. Cases of SMM were categorized and WHODAS-36 score was assessed according to hypertension, hemorrhage, or other conditions. Results: A total of 638 women were enrolled: 64 had mean scores below P90 (41.3). Of women scoring above P>90, those with morbidity had a higher mean score than those without (44.6% vs 36.8%, P=0.879). Women with higher WHODAS-36 scores presented more complications during pregnancy, especially hypertension (47.0% vs 37.5%, P=0.09). Mean scores among women with any complication were higher than those with no morbidity (19.0 vs 14.2, P=0.01). WHODAS-36 scores were higher among women with hypertensive complications (19.9 vs 16.0, P=0.004), but lower among those with hemorrhagic complications (13.8 vs 17.7, P=0.09). Conclusions: Complications during pregnancy, childbirth, and the puerperium increase long-term WHODAS-36 scores, demonstrating a persistent impact on functioning among women, up to 5 years postpartum. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|